Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SinoNasal Microbiota Transfer (SNMT) to Treat Chronic Rhinosinusitis: A Randomized, Double-blind, Placebo-controlled Trial

NCT05454072 is registered in ClinicalTrials.gov with Amin Javer as lead sponsor.

NCT NCT05454072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05454072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SinoNasal Microbiota Transfer (SNMT) to Treat Chronic Rhinosinusitis: A Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Amin Javer
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 15, 2022
Completion date
June 30, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sinus disease, sinus infection, sinus infection chronic, sinusitis, chronic